Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type

This statistic depicts the number of biotech orphan drugs available on the Italian pharmaceutical market between 2016 and 2017, by type. According to data, most of the biotech products available aimed at treating rare diseases were based on proteins obtained through recombinant DNA (15 treatments). Pertaining to gene therapy and tissue engineering only one treatment each was available in Italy up to 2017.

Number of biotech orphan drugs marketed in Italy between 2016 and 2017, by type

Number of biotech drugs in units
--
--
--
--
Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

November 2017

Region

Italy

Survey time period

2016 to 2017

Supplementary notes

The figure for the year 2014 was previously published by the source.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical market in Italy"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.